Literature DB >> 24937885

AAVP Symposium: new approaches in the study of animal parasites.

T R Klei, S R Chirgwin, G Solano-Aguilar, T Shea-Donohue, K Madden, H Dawson, T Ledbetter, J Urban, L C Gasbarre, T Sonstegard, C P Van Tassell, R Araujo.   

Abstract

The following three papers are a very small window onto the types of research being pursued by members of the American Association of Veterinary Parasitologists. They are related by the fact that newer areas in the biology of parasites and their hosts are discussed. The first paper by Dr. Tom Klei, gives a brief view of the interactions between host and parasite of the fascinating organism Wolbachia, a parasite of parasites. The second paper by Dr. Gloria Solano-Aguilar addresses the use of probiotics to alter the host–parasite interface and influence host resistance. The final paper by Dr. Lou Gasbarre outlines an example of integration of the genomics revolution into Veterinary Parasitology. While the subjects are diverse, they demonstrate the vitality of the AAVP.

Entities:  

Mesh:

Year:  2004        PMID: 24937885     DOI: 10.1016/j.vetpar.2004.05.011

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  2 in total

Review 1.  Safety assessment of probiotics for human use.

Authors:  Mary Ellen Sanders; Louis M A Akkermans; Dirk Haller; Cathy Hammerman; James Heimbach; Gabriele Hörmannsperger; Geert Huys; Dan D Levy; Femke Lutgendorff; David Mack; Phoukham Phothirath; Gloria Solano-Aguilar; Elaine Vaughan
Journal:  Gut Microbes       Date:  2010-03-04

2.  Parasite-Probiotic Interactions in the Gut: Bacillus sp. and Enterococcus faecium Regulate Type-2 Inflammatory Responses and Modify the Gut Microbiota of Pigs During Helminth Infection.

Authors:  Laura J Myhill; Sophie Stolzenbach; Helena Mejer; Lukasz Krych; Simon R Jakobsen; Witold Kot; Kerstin Skovgaard; Nuria Canibe; Peter Nejsum; Dennis S Nielsen; Stig M Thamsborg; Andrew R Williams
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.